fludeoxyglucose f 18
Generic: fludeoxyglucose f-18
Labeler: mayo clinicDrug Facts
Product Profile
Brand Name
fludeoxyglucose f 18
Generic Name
fludeoxyglucose f-18
Labeler
mayo clinic
Dosage Form
INJECTION
Routes
Active Ingredients
fludeoxyglucose f-18 240 mCi/mL
Manufacturer
Identifiers & Regulatory
Product NDC
52670-551
Product ID
52670-551_46dfe404-a820-7746-e063-6394a90afb00
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203612
Listing Expiration
2026-12-31
Marketing Start
2013-08-05
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
52670551
Hyphenated Format
52670-551
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fludeoxyglucose f 18 (source: ndc)
Generic Name
fludeoxyglucose f-18 (source: ndc)
Application Number
ANDA203612 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 240 mCi/mL
Packaging
- 30 mL in 1 VIAL, MULTI-DOSE (52670-551-30)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "46dfe404-a820-7746-e063-6394a90afb00", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["153b650d-7b69-4880-a72a-a5f13059d248"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["Mayo Clinic"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, MULTI-DOSE (52670-551-30)", "package_ndc": "52670-551-30", "marketing_start_date": "20130805"}], "brand_name": "Fludeoxyglucose F 18", "product_id": "52670-551_46dfe404-a820-7746-e063-6394a90afb00", "dosage_form": "INJECTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "52670-551", "generic_name": "Fludeoxyglucose F-18", "labeler_name": "Mayo Clinic", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose F 18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "240 mCi/mL"}], "application_number": "ANDA203612", "marketing_category": "ANDA", "marketing_start_date": "20130805", "listing_expiration_date": "20261231"}